[Synthesis and testing of potential antiparkinson agents. 2. Biologically active silicium derivatives].
D000818:Animals; D000978:Antiparkinson Agents / Q000138:chemical synthesis* / Q000627:therapeutic use / Q000633:toxicity; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D006868:Hydrolysis; D051379:Mice; D012821:Silanes / Q000138:chemical synthesis* / Q000627:therapeutic use / Q000633:toxicity; D012825:Silicon / Q000138:chemical synthesis*; D014202:Tremor / Q000188:drug therapy
D000978:Antiparkinson Agents; D012821:Silanes; D012825:Silicon
Synthese und Testung potentieller Antiparkinsonmittel 2. Mitteilung: Biologisch aktive Siliciumverbindungen.